Complementary medicine use during cancer treatment and potential herb-drug interactions from a cross-sectional study in an academic centre.

Détails

ID Serval
serval:BIB_EB0D132F2B63
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Complementary medicine use during cancer treatment and potential herb-drug interactions from a cross-sectional study in an academic centre.
Périodique
Scientific reports
Auteur(s)
Jermini M., Dubois J., Rodondi P.Y., Zaman K., Buclin T., Csajka C., Orcurto A., E Rothuizen L.
ISSN
2045-2322 (Electronic)
ISSN-L
2045-2322
Statut éditorial
Publié
Date de publication
25/03/2019
Peer-reviewed
Oui
Volume
9
Numéro
1
Pages
5078
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: epublish
Résumé
Complementary medicine (CM) is used by one third to one half of cancer patients throughout the world. The objective of this study was to describe the prevalence of CM use and the potential for interactions with cancer treatments in an academic oncology centre. A cross-sectional study was conducted among patients undergoing current cancer treatment. Among 132 included patients, 56% had used CM since their cancer diagnosis and 45% were using CM during cancer treatment at the time of the survey. The main CM used were green tea (35%), herbal tea (35%), homeopathy (27%), dietary supplements (27%), and herbal medicines (27%). A small majority of patients (58%) spontaneously mentioned the use of CM to their oncologist. Of 42 identified combinations of concomitant use of biologically based CM and anticancer agents among the study patients, the potential for pharmacokinetic interactions of clinical relevance was not expected in 17 combinations (40%), hypothetical and deemed unlikely in 23 (55%), and of probable low clinical relevance in 2 (5%). Considering the high prevalence of CM use, active enquiries should be made by healthcare professionals to detect symptoms that may relate to CM tolerance and effects or that suggest interactions between CM and cancer treatments.
Pubmed
Web of science
Open Access
Oui
Création de la notice
15/04/2019 7:02
Dernière modification de la notice
08/11/2019 14:26
Données d'usage